Asthma and broncho-hyperresponsiveness PBL NOTES
1) Revise the principle of alveolar-capillary gas exchange
Deoxygenated blood reach alveoli by pulmonary circulation
Oxygenated blood returns to left side of heart
CO2 released in blood in capillaries to be exhaled
2) Revise the commonly measured parameters of pulmonary function tests and their clinical uses
FVC: indicator of lung size + capacity = max air forcefully exhaled after taking a deep breath
PFT: non-invasive spirometry-based tests that measures lung function + supports diagnosis
FEV1: amount of air forcefully exhaled after first second
FEV1/FVC: to diagnose obstructive and restrictive lung disease
Total Residual Volume (TRV) (6L) - amount of air remained in lungs after maximal expiration
Increased in obstructive due to airway narrowing
Total lung capacity (TLC) - total volume of air in lungs after a maximal inspiration
Increased in obstructive due to increased residual volume
Decreased in restrictive due to failure of lung expansion
3) Recognize the pathophysiology of restrictive and obstructive lung diseases and how they are diagnosed
Restrictive: can't fully expand lungs, lungs cannot be fully filled with air → reduced FDV and a FEV1
Intrinsic: problems with alveoli + interstation (other fluid)
e.g. pulmonary fibrosis, sarcoidosis (inflammation of lungs, macrophages surrounding a foreign object such as bacteria to stop it from spreading)
Extrinsic: diaphragm, muscles, pleura, chest wall
Pleural effusion, spinal scoliosis (deviation of normal spine curvature)
Result in decreased elasticity of the lungs or difficulty in expansion of lungs
Obstructive: airway narrowing causes problems with exhaling the air
Air is exhaled at a slower rate and higher residual volume after exhalation
Diagnosis:
FEV1:FVC
If under 80% = Obstructive (FEV1 affected more)
If above 80% = Restrictive (FVC affected more)
4) Pathophysiology of bronchial hyper-responsiveness in asthma
Bronchial hyper-responsiveness (Asthma): exaggerated bronchiole constrictor response to bronchiole inhaled stimuli
Cause: large amounts of IGE antibodies reacting with specific antigens
IGE is attached to mast cells near bronchioles
IGE reacts with antigen → degranulation of mast cells → releases histamine → histamine acts on histamine 1 receptors on bronchiole smooth muscle cells → bronchoconstriction
IGE also bind with eosinophils → release of eosinophilic chemicals → activation of cholinergic pathway → increased ACh release from parasympathetic neurons that innervate the airways → smooth muscle contraction + bronchoconstriction
Inflammatory markers including IL-1 + TNFa released by T-lymphocytes → inflammation → Obstruction → bronchoconstriction
Inflammation releases bradykinin → bronchoconstriction in two ways:
Indirect: Activates thromboxane A2 → activates cholinergic pathway → ACh → smooth muscle contraction → bronchoconstriction
Direct: direct activation of cholinergic pathway
All leads of airway narrowing and increased restriction
5) Mechanisms of arterial blood gas abnormalities in asthma
Low O2 and high CO2 and low HCO3- → activates peripheral and central chemoreceptors
Activation of receptors leads to activation of respiratory system
increased RR and depth of ventilation (hyperventilation)
HCO3- binds with H+ to form CO2 to be exhaled → HCO3- is low
asthma = respiratory acidosis without any buffer
Low O2 due to impaired gas exchange
6) Physiological significance of ventilation-perfusion relationship and how V/Q mismatch is brought about and how the lungs compensate to correct pathological V/Q mismatch
V/Q - displays the efficiency of the air reaching alveoli and the flow of blood in capillaries
low V/Q - result of perfusion of poorly ventilated alveoli due to obstruction
asthma
COPD
high V/Q - result of ventilation of poorly perfused alveoli; not enough blood coming in and reaching capillaries
Pulmonary oedema
Compensation:
Low V/Q
Hypoxic vasoconstriction: when V/Q ratio is more blood and less air, results in directing the blood from the hypoxic areas to other areas → decreasing the perfusion of hypoxic regions + increasing V/Q ratio
High V/Q
Bronchoconstriction: when V/Q ratio is high there is more air and less blood, results in bronchoconstriction to reduce the volume of air that reaches the under perfused regions → correcting the V/Q ratio
7) Understand the pathogenesis of reversible and irreversible obstructive lung diseases along with their diagnosis
Reversible: asthma bronchial hyper-responsiveness
Irreversible: COPD
Definition: chronic airway narrowing/inflammation + tissue destruction → chronic airway obstruction + remodeling; results in the irreversibility of the disease
Pathogenesis:
a) Smoking ciggarretes → Activation of immune system in airways → release of proinflammatory cytokines + chemotactic factors → increased recruitment of neutrophils, macrophages, cytoxic, helper T cells, and proteases (results in remodeling) → inflammation of bronchi + structural changes to parenchyma → chronic bronchitis and emphysema
b) Inflammation lead to goblet cell proliferation → increased mucus production → impaired ciliary function → recurrent infection → bronchitis
Both lead to airway obstruction
Diagnosis: based on measurements of reversibility of bronchoconstriction by a bronchodilator challenge (spirometry based)
Irreversible (COPD): minimum reversal of airway narrowing post bronchodilator challenge
If FEV1 is higher than 12% = reversible
If FEV1 is lower than 12% = irreversible
8) Contrast the effects of reversible and irreversible obstructive lung diseases on the heart and pulmonary circulation
Irreversible right side of heart
Chronic airway narrowing → alveolar hypoxia (decreased V/Q) → hypoxic pulmonary vasoconstriction → increased right ventricular afterload → increased right ventricular pressure + volume → increased right ventricular enlargement + hypertrophy → tricuspid valve stretch → regurgitation of blood in right atrium → increased right atrial pressure + volume → atrial enlargement → increased CVP + JVP → murmur + right side heart failure
Reversible :
increased histamine (vasodilator) → decreased systemic BP + increased HR (compensatory mechanism)
short term
rare to occur
less effect on heart and lungs due to acute hypoxic vasoconstriction